Raybow Pharmaceutical, a global pharmaceutical chemistry services provider, agreed to acquire PharmAgra Labs, a contract chemistry organization. Financial terms were not disclosed. "Raybow's European and US clients will appreciate the option for contract services within the US The PharmAgra team has a proven track record established during their 20 years of custom synthesis services. Coupled with existing capacity ranging from grams to multi tons, we now have the flexibility to accommodate all of our clients' phase-appropriate outsourcing activities on multiple continents," Bin Wang Raybow CEO.